retroperitoneal lymph node dissection


Also found in: Acronyms, Wikipedia.

retroperitoneal lymph node dissection

surgical removal of lymph nodes bilaterally behind the peritoneum, and the lymph channels and fat around both renal pedicles, the vena cava, and the aorta, including the bifurcation of the aorta. The dissection is usually performed in an attempt to eliminate sites of lymphoma or metastases from malignancies originating in pelvic organs or genitalia. Also called radical lymphadenectomy.

retroperitoneal lymph node dissection

Surgery to remove the lymph nodes behind the peritoneum. This has been found an effective measure in certain cases of testicular cancer that have spread to the lymph nodes. In non-seminomatous cancer the cure rate by this means has approached 98 per cent.
References in periodicals archive ?
Initial series of robot-assisted laparoscopic retroperitoneal lymph node dissection for clinical stage I non-seminomatous germ cell testicular cancer.
3 It was most commonly described after lower extremities vascular surgeries, abdominal aortic surgeries and retroperitoneal lymph node dissection.
9,10 Chylous ascites was accumulation of lymphatic drainage and seen in retroperitoneal lymph node dissection surgeries.
Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer.
The treatment of testicular cancer consists of radical orchidectomy, cisplatin-based chemotherapy radiotherapy, and retroperitoneal lymph node dissection (RPLND).
Lymph node yield in primary retroperitoneal lymph node dissection for nonseminoma germ cell tumours.
Complications of primary nerve-sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: Experience of the German Testicular Cancer Study Group.
Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?
Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumour s: AUO Trial AH 01/94 by the German Testicular Cancer Study Group.
A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumour s undergoing retroperitoneal lymph node dissection only.
The benefit of postchemotherapy retroperitoneal lymph node dissection (RPLND) for patients with nonregional nodal metastasis has been examined in a prospective fashion at the MD Anderson Cancer Center (MDACC).
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

Full browser ?